The Food and Drug Administration approved expanded labeling for CAS Medical Systems Inc.'s (Nasdaq: CASM) brain monitoring device to include infants under 2.5 kilograms in weight. The stock price leaped $1.18 to close at $2.61.
FDA Expands Labeling For CAS' Brain Monitoring Device
August 25, 2009 at 17:36 PM EDT
